Comparing the Efficacy: What Do the Studies Say
[1] [2] These results represent a degree of weight reduction not previously observed with any pharmacological agent in a trial of this duration, though Phase 3 data are required before firm conclusions can be drawn
Schallreuter KU, Krger C, Wrfel BA, Panske A, Wood JM
Recent trials with Liraglutide [70] and Tirzapetide [71] support the notion that despite the reductions in lean muscle mass observed, this is not pathologically disproportionate to the degree of weight loss achieved
These side effects often decrease over time as your body adapts to the medication
Its the most effective method for delivering this essential nutrient directly where it's needed, allowing for higher concentrations and more immediate effects